The FDA approved the first treatment for the rare genetic disorder CLN2 disease that typically affects young children. What are the side effects of the therapy, and how much does it cost per year?
BioMarin's Brineura Gets FDA Approval As First Treatment For Type Of Batten Disease
Tech Times - 29 Apr 2017 04:57
The FDA approved the first treatment for the rare genetic disorder CLN2 disease that typically affects young children. What are the side effects of the therapy, and how much does it cost per year?
Share this Article
Recommended